A Drug Company’s Forced Sales, and a Family Feud in Shanghai
A family of biotech contracting companies in Wuxi has begun selling offshore assets under pressure from Western governments worried about national security. And a family feud in Shanghai has left a $1 billion luxury villa complex in limbo.
2269.HK
2359.HK
Recent Articles
A Drug Company’s Forced Sales, and a Family Feud in Shanghai
2269.HK
2359.HK
RELATED ARTICLES
-
WuXi Biologics sells vaccine plant as new U.S. law looms
2269.HK
- Shanghai family feud ties up $1 billion in property, offers lesson for investors
-
U.S. rethinks timing of biotech crackdown, easing pressure on WuXi family
2269.HK 2359.HK 2268.HK
- CHINA BULLETIN: Manufacturing Déjà Vu
-
WuXi AppTec posts lower profits but avoids more share price pain
2359.HK 603259.SHG
-
WuXi AppTec mulls gene unit sale to soften U.S. legal blow
2359.HK 603259.SHG
Discover hidden China stock gems in our weekly newsletter